Geriatrics | Page 21 of 63 | Links Medicus Content Curation & Alerts in Medicine

⬇️ 💉Less medications (& ⬆️ awareness of behavioural interventions) is more in #delirium, common, challenging/costly (but often preventable) in #ICU. Despite lacking evidence, medications widely used.
Prevent/minimize addressing suspected contributors!
📎 https://t.co/fYWAsIcuiZ pic.twitter.com/DyC3agSP7w

— Intensive Care Medicine (@yourICM) April 30, 2022

M-A: Comparative safety and efficacy of cognitive enhancers for Alzheimer’s dementia.

1 May, 2022 | 23:10h | UTC

Comparative safety and efficacy of cognitive enhancers for Alzheimer’s dementia: a systematic review with individual patient data network meta-analysis – BMJ Open

Study Commentary | People of all ages benefit from drugs to lower blood pressure.

29 Apr, 2022 | 08:18h | UTC

People of all ages benefit from drugs to lower blood pressure – National Institute for Health and Care Research

Original Study: Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis – The Lancet

Systematic Review: Diagnostic test accuracy of remote, multidomain cognitive assessment (telephone and video call) for dementia.

29 Apr, 2022 | 11:09h | UTC

Diagnostic test accuracy of remote, multidomain cognitive assessment (telephone and video call) for dementia – Cochrane Library

Summary: How accurate are remote, virtual assessments at diagnosing dementia? – Cochrane Library

Study Commentary | Palliative and end of life care should not wait for a prediction of death.

28 Apr, 2022 | 10:44h | UTC

Palliative and end of life care should not wait for a prediction of death – National Institute for Health and Care Research

Original Study: Timely community palliative and end-of-life care: a realist synthesis – BMJ Supportive & Palliative Care

Systematic Review: Psychological treatments for depression and anxiety in dementia and mild cognitive impairment.

28 Apr, 2022 | 10:33h | UTC

Psychological treatments for depression and anxiety in dementia and mild cognitive impairment – Cochrane Library

Summary: Psychological treatments for depression and anxiety in dementia and mild cognitive impairment – Cochrane Library

Podcast: Lower urinary tract symptoms, benign prostatic hyperplasia, and urinary incontinence.

28 Apr, 2022 | 08:00h | UTC

LUTS, BPH, and Urinary Incontinence Triple Distilled – The Curbsiders

USPSTF Recommendation Statement: Aspirin Use to Prevent Cardiovascular Disease.

27 Apr, 2022 | 08:16h | UTC

Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement – JAMA

Author Interview: USPSTF Recommendation: Aspirin Use for Cardiovascular Disease – JAMA

Modeling Study: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force – JAMA

Evidence Report: Aspirin Use to Prevent Cardiovascular Disease and Colorectal CancerUpdated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Patient Page: Use of Aspirin to Prevent Cardiovascular Disease – JAMA

Editorials:

Should Patients Take Aspirin for Primary Cardiovascular Prevention? Updated Recommendations From the US Preventive Services Task Force

Whom to Treat for Primary Prevention of Atherosclerotic Cardiovascular Disease: The Aspirin Dilemma – JAMA Internal Medicine

Aspirin for Primary Prevention—Time to Rethink Our Approach – JAMA Network Open

USPSTF Report on Aspirin for Primary Prevention – JAMA Cardiology

Commentaries:

USPSTF Report on Aspirin for Primary Prevention – American College of Cardiology

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention – TCTMD

Daily aspirin offers little to no benefit for most adults trying to prevent heart disease, new report says – STAT

U.S. Task Force Rejects Daily Aspirin for Heart Health in People Over 60 – HealthDay

Longitudinal associations of mental disorders with dementia: 30-year analysis of 1.7 million New Zealand citizens.

27 Apr, 2022 | 07:51h | UTC

Longitudinal Associations of Mental Disorders With Dementia: 30-Year Analysis of 1.7 Million New Zealand Citizens – JAMA Psychiatry

News Release: Mental disorders may increase risk for subsequent dementia – University of Michigan

Commentary: Mental Disorders Tied to Subsequent Dementia Onset – HealthDay

Commentary on Twitter

In this longitudinal population-register study of 1.7 million New Zealand citizens, individuals with #mentalhealth disorders had elevated risk for #dementia when followed up years later. https://t.co/kkOUOnHEXE

— JAMA Psychiatry (@JAMAPsych) April 15, 2022

New horizons in evidence-based care for older people: individual participant data meta-analysis.

27 Apr, 2022 | 07:50h | UTC

New horizons in evidence-based care for older people: individual participant data meta-analysis – Age and Ageing

Persistent COVID-19 symptoms in a community study of 606,434 people in England.

26 Apr, 2022 | 08:48h | UTC

Persistent COVID-19 symptoms in a community study of 606,434 people in England – Nature Communications

Commentary on Twitter

Thirty-eight percent of participants from a community-based study of symptoms following COVID-19 reported persistent symptoms that lasted 12 weeks or more, according to an article published in @NatureComms. https://t.co/sAEutdOkSS pic.twitter.com/oCyyXGIRbk

— Nature Portfolio (@NaturePortfolio) April 20, 2022

Cohort Study: Association of cumulative blood pressure with cognitive decline, dementia, and mortality.

25 Apr, 2022 | 00:35h | UTC

Association of Cumulative Blood Pressure With Cognitive Decline, Dementia, and Mortality – Journal of the American College of Cardiology

Commentary: Association of Blood Pressure With Cognitive Decline, Dementia, and Mortality – American College of Cardiology

Anticholinergic medications and dementia: should we be worried?

25 Apr, 2022 | 00:14h | UTC

Commonly-prescribed drugs and dementia: should we be worried? – Evidently Cochrane

Original Review:

Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome – Cochrane Library

Editorial: Anticholinergic drugs and dementia: time for transparency in the face of uncertainty – Cochrane Library

Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models – Drugs & Aging

Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study – JAMA Internal Medicine

How well do you know your anticholinergic (antimuscarinic) drugs? – Therapeutics Initiative

Anticholinergic drugs and risk of dementia: case-control study – The BMJ

Commentary on Twitter

Commonly-prescribed drugs & dementia: should we be worried? https://t.co/pvWxT6q48Z A @CochraneUK blog: Jodi Watt (a researcher @UofGlasgow) explores the @CochraneDCIG evidence on whether #anticholinergics might increase people’s risk of future memory problems, or even #dementia

— The Cochrane Library (@CochraneLibrary) April 22, 2022

Cohort Study: Progression to diabetes among older adults with Hemoglobin A1c–defined prediabetes was around 5% after a medium follow up of 2.3 years.

25 Apr, 2022 | 00:01h | UTC

Progression to Diabetes Among Older Adults With Hemoglobin A_1c–Defined Prediabetes in the US – JAMA Network Open

Commentaries:

How Often Does Prediabetes in Seniors Escalate to Full-Blown Disease? – MedPage Today (link to abstract – $ for full-text)

New Research Explores Diabetes Progression Rate in Older Adults with Prediabetes – HCP Livre

Commentary on Twitter

This cohort study found that older adults with prediabetes showed higher progression to diabetes (5.3%) compared to prior studies. https://t.co/cHP7jyV7jT

— JAMA Network Open (@JAMANetworkOpen) April 21, 2022